Rezultati

еНаука >  Резултати >  Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients With HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II Study
Title: Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients With HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II Study
Authors : O'Shaughnessy, Joyce; ...; Cvetanovic, Ana S; ...; Stamatovic, Ljiljana
Issue Date: 2025
Publication: CLINICAL BREAST CANCER
ISSN: 1526-8209 Clinical Breast Cancer Search Idenfier
Type: Article
Collation: vol. 25 br. 6 str. 554-559.e1
DOI: 10.1016/j.clbc.2025.04.016
WoS-ID: 001563948200001
Scopus-ID: 2-s2.0-105007063935
URI: https://enauka.gov.rs/handle/123456789/999591
Project: F. Hoffmann-La Roche Ltd.
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
22M22

2
SCOPUSTM
2
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.